Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $76.2250 (1.99%) ($76.2250 - $76.2250) on Wed. Dec. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.29% (three month average) | RSI | 76 | Latest Price | $76.2250(1.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.2% a day on average for past five trading days. | Weekly Trend | EDIT advances 14% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) IWO(60%) IWC(57%) IBUY(56%) ARKG(55%) | Factors Impacting EDIT price | EDIT will decline at least -3.645% in a week (0% probabilities). VIXM(-30%) UUP(-15%) VXX(-12%) TBT(-7%) UNG(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.645% (StdDev 7.29%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $80.22(-4.98%) | 10 Day Moving Average | $76.04(0.24%) | 20 Day Moving Average | $63.29(20.44%) | To recent high | -9.8% | To recent low | 181.4% | Market Cap | $4.734b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |